Año: 2021
Journal Impact Factor (JIF): 9.9170
Categoría | Edición | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|---|
GASTROENTEROLOGY & HEPATOLOGY | SCIE | 13/93 | Q1 | T1 | D2 |
Año: 2021
Journal Citation Indicator (JCI): 1,620
Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
---|---|---|---|---|---|
GASTROENTEROLOGY & HEPATOLOGY | 16/136 | Q1 | T1 | D2 | 88,60 |
Año:
2021
CiteScore:
8,100
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Gastroenterology | 17/149 | Q1 | T1 | D2 |
Internal Medicine | 22/134 | Q1 | T1 | D2 |
Hepatology | 15/70 | Q1 | T1 | D3 |
Immunology and Allergy | 51/200 | Q2 | T1 | D3 |
SJR año:
2021
Factor de Impacto:
2,835
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Gastroenterology | 6/165 | Q1 | T1 | D1 |
Hepatology | 7/78 | Q1 | T1 | D1 |
Immunology and Allergy | 21/224 | Q1 | T1 | D1 |
Internal Medicine | 9/167 | Q1 | T1 | D1 |
Agencia | Código de Proyecto |
---|---|
Allergan Pharmaceutical International Ltd. | - |
Bristol-Myers-Squibb Company | - |
EASL International Liver Foundation | - |
Genfit | - |
Gilead Sciences Europe Ltd. | - |
Government of Catalonia through the CERCA Programme | - |
Horizon 2020 Framework Program of the European Union | 634413 |
IMI2 Program of the European Union | 777377 |
Intercept | - |
Pfizer Inc. | - |
Resoundant Inc. | - |
Spanish Ministry of Science, Innovation and Universities Miguel Servet grant (Instituto de Salud Carlos III/ESF, European Union) | CP18/00074 |
Spanish Ministry of Science, Innovation and Universities through the 'Centro de Excelencia Severo Ochoa 2019-2023' Programme | CEX2018-000806-S |
# | Autor |
---|---|
1 | |
2 | Palayew, A. |
3 | Carrieri, P. |
4 | Ekstedt, M. |
5 | Marchesini, G. |
6 | Novak, K. |
7 | Ratziu, V. |
8 | Romero-Gómez, M. |
9 | Tacke, F. |
10 | Zelber-Sagi, S. |
11 | Cortez-Pinto, H. |
12 | Anstee, Q. M. |